571
|
|
|
Glutamate metabotropic receptor 4 |
GPRC1D, MGLUR4, mGlu4 |
|
572
|
|
|
Glutamate metabotropic receptor 5 |
GPRC1E, MGLUR5, PPP1R86, mGlu5 |
Attention deficit hyperactivity disorder, Autism, Biliary tract cancer, Bipolar disorder, Breast cancer, Cancer, Basal cell carcinoma, Cardiac embolism, Cardioembolic stroke, Central nervous system cancer, Cervical cancer, Colorectal cancer, Diabetic neuropathy, Endometrial cancer, Endometriosis, Temporal lobe epilepsy, Esophageal cancer, Estrogen-receptor negative breast cancer, Gastric cancer, Glaucoma, Glioblastoma, Glioma, Hearing loss, Hepatocellular carcinoma, Hypertension, Insomnia, Lung cancer, Major depressive disorder, Melanoma, Neurotic disorder, Non-hodgkins lymphoma, Non-melanoma skin carcinoma, Obesity, Ovarian cancer, Ovarian serous carcinoma, Pancreatic cancer, Prostate cancer, Psychiatric disorders, Retinal detachment, Rheumatoid arthritis, Schizophrenia, Scoliosis, Squamous cell carcinoma, Status epilepticus, Tooth disease, Diabetes mellitus type 2, DepressionView all (32 more) |
573
|
|
|
Glutamate metabotropic receptor 6 |
CSNB1B, GPRC1F, MGLUR6, mGlu6 |
|
574
|
|
|
Glutamate metabotropic receptor 7 |
GLUR7, GPRC1G, MGLU7, MGLUR7, NEDSHBA, PPP1R87 |
Attention deficit hyperactivity disorder, Nonsyndromic intellectual disability, Bipolar disorder, Brain atrophy, Obstructive pulmonary disease, Colorectal adenoma, Colorectal cancer, Major depressive disorder, Developmental and epileptic encephalopathy, Endometriosis, Global developmental delay, Insomnia, Intellectual developmental disorder, Irritable bowel syndrome, Leprosy, Lung cancer, Migraine, Neurodevelopmental disorder, Oligodendroglioma, Orofacial cleft, Panic disorder, Psychiatric disorders, Schizophrenia, Scoliosis, Systemic sclerosis, Depression, Urinary tract infectionView all (12 more) |
575
|
|
|
Glutamate metabotropic receptor 8 |
GLUR8, GPRC1H, MGLUR8, mGlu8 |
Alzheimer disease, Anxiety disorder, Attention deficit hyperactivity disorder, Autism, Bipolar disorder, Brain injuries, Carotid artery disease, Diabetic retinopathy, Gastroesophageal reflux disease, Glioma, Hyperaldosteronism, Major depressive disorder, Metabolic syndrome, Mood disorder, Neurotic disorder, Obesity, Post-traumatic stress disorder, Schizophrenia, Small cell lung carcinoma, Creutzfeldt-jakob disease, Substance abuse, Diabetes mellitus type 2View all (7 more) |
576
|
|
|
Granulin precursor |
CLN11, FTD2, GEP, GP88, PCDGF, PEPI, PGRN |
Alzheimer disease, Amyotrophic lateral sclerosis, Bipolar disorder, Neuronal ceroid lipofuscinosis, Dementia, Major depressive disorder, Frontotemporal dementia, Frontotemporal dementia with or without amyotrophic lateral sclerosis, Frontotemporal dementia with motor neuron disease, Liver cirrhosis, Parkinson disease, Schizophrenia, Diabetes mellitus type 2 |
577
|
|
|
Gastrin releasing peptide |
BN, GRP-10, preproGRP, proGRP |
Amnesia, Colorectal cancer, Crohn disease, Head and neck neoplasms, Inflammatory bowel disease, Insomnia, Liver neoplasms, Metabolic syndrome, Pancreatic cancer, Proliferative diabetic retinopathy, Pruritus, Diabetes mellitus type 2, Venous thromboembolism |
578
|
|
|
Gastrin releasing peptide receptor |
BB2, BB2R, BRS2 |
|
579
|
|
|
Glutamate rich WD repeat containing 1 |
CDW4, DIAR14, GRWD, RRB1, WDR28 |
|
580
|
|
|
Glutaredoxin and cysteine rich domain containing 1 |
DFNB25, PPP1R88 |
Isolated sensorineural deafness, Nonsyndromic hearing loss, Basal cell carcinoma, Central nervous system cancer, Color vision deficiency, Deafness, Glioblastoma, Glioma, Hearing impairment, Hearing loss, Obesity, Oligodendroglioma, Schizophrenia, Scoliosis, Squamous cell carcinoma |
